← SynDRA
NVP-ADW742
SynDRA canonical compound SYN1953856 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | IGF1R |
|---|
| Mechanism of action | insulin growth factor receptor inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- insulin growth factor receptor inhibitor
Cross-references
Synonyms
- ADW-742
- UNII-MXS2N5862L
- ADW742
- MXS2N5862L
- CHEMBL399021
- 5-(3-(Benzyloxy)phenyl)-7-((1r,3r)-3-(pyrrolidin-1-ylmethyl)-cyclobutyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine
- 5-(3-(Benzyloxy)phenyl)-7-(cis-3-(pyrrolidin-1-ylmethyl)cyclobutyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine
- C28H31N5O
- 5-(3-Benzyloxyphenyl)-7-[trans-3-[(pyrrolidin-1-yl)methyl]cyclobutyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine
Look up NVP-ADW742 in the interactive SynDRA portal →